Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

ABS Biotechnologies

ABS Biotechnologies GmbH offers a drug screening platform using blood vessel cells for precision medicine.
2022
2-10
Tulln, Niederosterreich, Austria

Investment Funding

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information